LONDON, UK / ACCESSWIRE / January 16, 2018 / Active-Investors.com has just released a free research report on Boston Scientific Corp. (NYSE: BSX). If you want access to this report all you need to do ...
Boston ScientificBSX is hitting headlines with successive new developments, the latest feat being the company's Spectra WaveWriter Spinal Cord Stimulator System (SCS) getting an FDA nod. Per Boston ...
Boston Scientific Corp. won a nod from the FDA to market its Spectra Wavewriter spinal cord stimulator (SCS) system to treat pain. The Marlborough, Mass.-based company said its SCS works by sending ...
The FDA approved Boston Scientific's Spectra WaveWriter Spinal Cord Stimulator System. Here's what you should know: 1. The system is the first and only FDA-approved system that simultaneously provides ...
Boston Scientific announced Thursday it has received regulatory approval for a new treatment for chronic pain without the use of opioids. The product, the Spectra WaveWriter Spinal Cord Stimulator ...
System offers multiple non-drug therapies for people with chronic pain PARIS, Jan. 31, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra ...
MARLBOROUGH, Mass., Jan. 11, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Spectra WaveWriter™ Spinal ...
LONDON, UK / ACCESSWIRE / January 16, 2018 / Active-Investors.com has just released a free research report on Boston Scientific Corp. (NYSE: BSX). If you want access to this report all you need to do ...
The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...
- PARIS, Jan. 31, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System in Europe. The Spectra ...
The Spectra WaveWriter SCS System allows physicians and patients to specifically target one area of pain, or multiple areas, with one or both types of therapy to address individual needs. Patients are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback